Parnell Pharmaceuticals Holdings (Parnell Pharmaceuticals Holdings) Price-to-Tangible-Book : (As of Jun. 05, 2024)

View and export this data going back to 2014. Start your Free Trial

What is Parnell Pharmaceuticals Holdings Price-to-Tangible-Book?

As of today (2024-06-05), Parnell Pharmaceuticals Holdings's share price is $0.0001. Parnell Pharmaceuticals Holdings's Tangible Book per Share of Dec. 2018 for the quarter that ended in Dec. 2018 was $-1.26. Hence, Parnell Pharmaceuticals Holdings's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Parnell Pharmaceuticals Holdings's Price-to-Tangible-Book or its related term are showing as below:

PARNF's Price-to-Tangible-Book is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 2.31
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Parnell Pharmaceuticals Holdings's share price is $0.0001. Parnell Pharmaceuticals Holdings's Book Value per Sharefor the quarter that ended in Dec. 2018 was $-0.74. Hence, Parnell Pharmaceuticals Holdings's P/B Ratio of today is .

Parnell Pharmaceuticals Holdings Price-to-Tangible-Book Historical Data

The historical data trend for Parnell Pharmaceuticals Holdings's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Parnell Pharmaceuticals Holdings Price-to-Tangible-Book Chart

Parnell Pharmaceuticals Holdings Annual Data

Trend

Jun12

Jun13

Jun14

Dec15

Dec16

Dec17

Dec18

Price-to-Tangible-Book

Get a 7-Day Free Trial

3.68

19.40

Parnell Pharmaceuticals Holdings Semi-Annual Data
	Jun12	Jun13	Jun14	Dec15	Dec16	Dec17	Dec18
Price-to-Tangible-Book	Get a 7-Day Free Trial			3.68	19.40	-	-	-

Competitive Comparison of Parnell Pharmaceuticals Holdings's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, Parnell Pharmaceuticals Holdings's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Parnell Pharmaceuticals Holdings's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Parnell Pharmaceuticals Holdings's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Parnell Pharmaceuticals Holdings's Price-to-Tangible-Book falls into.

Parnell Pharmaceuticals Holdings Price-to-Tangible-Book Calculation

Parnell Pharmaceuticals Holdings's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2018 )
	=	0.0001	/	-1.256
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Parnell Pharmaceuticals Holdings Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Parnell Pharmaceuticals Holdings's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Parnell Pharmaceuticals Holdings (Parnell Pharmaceuticals Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Parnell Pharmaceuticals Holdings Ltd (OTCPK:PARNF) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

476 Gardeners Road, Unit 4, Century Estate, Alexandria, Sydney, NSW, AUS, 2015

Website

https://www.parnell.com

Parnell Pharmaceuticals Holdings Ltd is an Australia based veterinary pharmaceutical company. It is focused on developing, manufacturing and commercializing animal health solutions. The group manufactures and market products for companion animals and production animals. The firm also has a pipeline of drug products like Zydax, PAR121 and PAR122 and Luminous which covers therapeutic areas in orthopedics, dermatology, and nutraceuticals. The operating segments of the company are Companion animal, Production animal - U.S., Production animal - rest of world and Contract Manufacturing. It operates internationally and generates the majority of the revenue from the Production animal - U.S. segment which covers the group's reproductive hormone portfolio across production animal in the USA.